5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of 177Lutetium radiolabeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody J591 (177Lu-J591) in patients (pts) with metastatic androgen-independent prostate cancer (AIPC)
    Meeting Abstract

    Bander, N. H.; Nanus, D. M.; Milowsky, M. I.; Morris, M. J.; Jeske, S.; Vallabhajosula, S.; Goldsmith, S. J.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • The clinical state of the rising PSA level after definitive local therapy: A practical approach
    Book Section

    Morris, M. J.; Scher, H. I.
    In Wein, A. J.; Kavoussi, L. R.; Novick, A. C.; Partin, A. W.; Peters, C. A. (Eds.) Campbell-Walsh Urology. 9th ed (2007)

    Fulltext@MSK | Save
  • Testicular carcinoma
    Book Section

    Kondagunta, V.; Motzer, R. J.; Bosl, G. J.
    In Schrier, R. W. (Eds.) Diseases of the Kidney and Urinary Tract. 8th ed (2007)

    Fulltext@MSK | Save
  • Bladder cancer
    Book Section

    Galsky, M. D.; Bajorin, D. F.
    In Schrier, R. W. (Eds.) Diseases of the Kidney and Urinary Tract. 8th ed (2007)

    Fulltext@MSK | Save
  • Dx/Rx: Prostate cancer
    Book Whole

    Kampel, L. J.
    Jones and Bartlett Publishers (2007)

    Fulltext@MSK | Save
  • Chemotherapy for bladder cancer
    Book Section

    Galsky, M. D.; Bajorin, D. F.
    In Waxman, J. (Eds.) Urological Cancers in Clinical Practice (2007)

    Fulltext@MSK | Save
  • The PI3K/AKT and MAPK signaling cooperate to mediate translational initiation and cell survival in human tumors
    Meeting Abstract

    She, Q. B.; Ye, Q.; Zhen, W.; Solit, D.; Rosen, N.
    Cancer Research (2007)

    Fulltext@MSK | Save
  • Circulating angiogenic cells in metastatic prostate cancer: Assessment of the bone marrow vascular and peripheral blood vascular compartments
    Meeting Abstract

    Seandel, M.; Fleisher, M.; Hooper, A. T.; Rafii, S.; Scher, H. I.
    Cancer Research (2007)

    Fulltext@MSK | Save
  • Activating mutation in B-RAF disables normal feedback inhibition of MEK and results in increased output of the RAF/MEK/MAPK signaling pathway
    Meeting Abstract

    Pratilas, C. A.; Taylor, B.; Nelander, S.; Grbovic-Huezo, O.; Viale, A.; Solit, D.; Sander, C.; Rosen, N.
    Cancer Research (2007)

    Fulltext@MSK | Save
  • BRAF mutation predicts for MEK-dependence in non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Halilovic, E.; Pratilas, C.; Sawai, A.; Grbovic, O.; Rosen, N.; Solit, D. B.
    Cancer Research (2007)

    Fulltext@MSK | Save